Navigation Links
Forgotten but not gone -- how the brain takes care of things
Date:11/17/2008

er a special point of contact, called synapse, forms at the end of the appendage, information can be transferred from one cell to the next - and new information is learned. Once the contact breaks down, we forget what we have learned.

The subtle difference between learning and relearning

Although learning and memory were recently shown to be linked to the changes in brain structure mentioned above, many questions still remain unanswered. What happens, for example, when the brain learns something, forgets it after a while and then has to learn it again later? By way of example, we know from experience that, once we have learned to ride a bicycle, we can easily pick it up again, even if we haven't practiced for years. In other cases too, "relearning" tends to be easier than starting "from scratch". Does this subtle difference also have its origins in the structure of the nerve cells?

Cell appendages abide the saying "a bird in the hand "

Scientists at the Max Planck Institute of Neurobiology have now managed to show that there are indeed considerable differences in the number of new cell contacts made - depending on whether a piece of information is new or is being learned second time around. Nerve cells that process visual information, for instance, produced a considerably higher number of new cell contacts if the flow of information from their "own" eye was temporarily blocked. After approximately five days, the nerve cells had rearranged themselves so as to receive and process information from the other eye - the brain had resigned itself to having only one eye at its disposal. Once information flowed freely again from the eye that had been temporarily closed, the nerve cells resumed their original function and now more or less ignored signals from the alternative eye.

"What surprised us most, however, was that the majority of the appendages which developed in response to the information blockade, continu
'/>"/>

Contact: Dr. Mark Huebener
mark@neuro.mpg.de
Max-Planck-Gesellschaft
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Yam bean a nearly forgotten crop
2. Yam bean a nearly forgotten crop
3. Yale researchers unravel mystery of brain aneurysms
4. Interaction between gene variants may alter brain function in schizophrenia
5. Social interactions can alter gene expression in the brain, and vice versa
6. Pitt research identifies new target in brain for treating schizophrenia
7. Brain recognizes verbal oh dear wave
8. Ultrasound shown to exert remote control of brain circuits
9. How we see objects in depth: The brains code for 3-D structure
10. Building the blood-brain barrier
11. Streamlining brain signals for speed and efficacy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Forgotten but not gone -- how the brain takes care of things
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... people are annoyed by upspeak: the habit of making a sentence ... intonation in speech as in upspeak may be a ... PLoS ONE finds that people use the same brain ... suggest that people learn by imitating through so-called mirror neurons. This ...
... Led by Professor Gail Taylor, an expert on plants ... of scientists across the UK will track the path of ... photosynthesis, as it flows through the plant to the soil, ... matter in the soil in which the plant is growing. ...
... by emphysema and/or chronic bronchitis. It destroys the ... aspects of breathing, which prevents necessary gas exchange. ... of lung infections. These symptoms are associated with ... air sacs, which usually inflate with air during breathing ...
Cached Biology News:Music in speech equals empathy in heart? 2Solutions to climate change: Using trees and grasses to capture carbon and produce energy 2New potential to treat chronic obstructive pulmonary disease 2
(Date:2/26/2015)... Feb. 26, 2015  Spark Therapeutics (NASDAQ: ONCE ... will participate in the Cowen and Company Health Care ... Eastern, at the Boston Marriott Copley Place. ... presentation from the Cowen conference, please visit the "Upcoming ... the Spark Therapeutics website at www.sparktx.com .  A ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 On Wednesday, ... to building a nationwide Clostridium difficile (C. diff) awareness ... diff burden study by the Centers for Disease Control ... caused almost half a million infections among Americans in ... nursing homes. , The study also estimates that ...
(Date:2/26/2015)... LONDON , February 26, 2015 ... of subjects into PEACH, the first pivotal trial ... dialysis dependent chronic kidney disease (DD-CKD), has completed ... achieved. PT20, invented by leading UK-based ... licensed by Phosphate Therapeutics, is a novel phosphate ...
(Date:2/25/2015)... , Feb. 25, 2015 truBrain ... is featured in this week,s Power Pitch segment ... to discuss the company,s traction and growth strategy, ... the crowd funding site CircleUp. The ... that are validated by neurotechnology, while also discussing ...
Breaking Biology Technology:Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2
... ... the upside of not only producing a low sodium meat product but with better ... ... of value-added ingredients into the natural food, nutraceutical and medical food market, is proud ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing 2New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing 3Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease 2Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 2Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 4Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 5Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 6Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 7